Invest and Sell PathAI Stock

PathAI stock price

Forge Price ¹

Price not yet available

Last Closed Trade ²

Close Date

xx/xx/xx

Last Closed Trade Price

$xx.xx

Last Funding Round (LFR)

Date

xx/xx/xx

Price per Share

$xx.xx

Access Stock Price

PathAI funding rounds and valuation

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	05/19/2021	Series C	$165MM	$xx.xx	$1.11B	8vc, Adage, Biospring Partners, Bristol-Myers Squibb Company, D1 Capital Partners, General Atlantic, General Catalyst, Kaiser Permanente, Kdt Ventures, Labcorp, Merck Global Health Innovation Fund, Polaris Partners, Refactor Capital, Tiger Global Management
Price per Share $xx.xx Shares Outstanding 5,593,222 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Adage, Biospring Partners, Bristol-Myers Squibb Company, D1 Capital Partners, General Atlantic, General Catalyst, Kaiser Permanente, Kdt Ventures, Labcorp, Merck Global Health Innovation Fund, Polaris Partners, Refactor Capital, Tiger Global Management
	11/04/2019	Series B	$75MM	$xx.xx	$410.6MM	Bristol-Myers Squibb Company, Labcorp, Merck Global Health Innovation Fund
Price per Share $xx.xx Shares Outstanding 4,993,331 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Bristol-Myers Squibb Company, Labcorp, Merck Global Health Innovation Fund
	11/03/2017	Series A	$11.2MM	$xx.xx	$55.11MM	8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
Price per Share $xx.xx Shares Outstanding 3,449,295 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
	11/03/2017	Series A1	$3.81MM	$xx.xx	$55.11MM	8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
Price per Share $xx.xx Shares Outstanding 2,168,963 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
	11/03/2017	Series A2	$209,998.00	$xx.xx	$55.11MM	8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
Price per Share $xx.xx Shares Outstanding 99,492 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
	11/03/2017	Series A3	$164,997.00	$xx.xx	$55.11MM	8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
Price per Share $xx.xx Shares Outstanding 67,004 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
	11/03/2017	Series A4	$106,250.00	$xx.xx	$55.11MM	8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital
Price per Share $xx.xx Shares Outstanding 156,780 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors 8vc, Danhua Capital, General Catalyst, Kdt Ventures, Pillar Companies, Refactor Capital

Access Stock Price

PathAI stock FAQs

To buy and sell PathAI stock

Can you buy PathAI stock?

As PathAI is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like PathAI, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy PathAI stock?

To invest in a private company like PathAI through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell PathAI stock?

Yes, you may sell the PathAI stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell PathAI stock?

If you hold private company shares of PathAI – whether as an employee or an early investor – Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your PathAI on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

To learn more about PathAI stock

Is PathAI a public company?

No, PathAI is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is PathAI’s stock price?

PathAI is a privately held company and therefore does not have a public stock price. However, you may access PathAI private market stock price with Forge Data.

What is PathAI’s stock ticker symbol?

PathAI does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Leadership and board

Leadership

Andrew Beck

Co-Founder & Chief Executive Officer

Aditya Khosla

Co-Founder & Chief Technology Officer

Tiffany Freitas

Chief Business Officer

Andy Moffit

Chief People Officer

Board

Stanley Lapidus

Daktari Diagnostics

PathAI news and media highlights

Yahoo Finance 11/16/2023

PathAI Announces AISight Support of DICOM Standards and Commits to Being a Leader in Integrated Enterprise Image Architecture and Strategy

PathAI, a technology company specializing in AI-powered pathology solutions, has announced support for DICOM standards and aims to be a leader in integrated enterprise image architecture and strategy. This development marks a significant step towards PathAI's vision of interoperable pathology systems. The firm is also planning to launch its DICOMweb API, which will enhance its integration with organizations‚Äô enterprise image management and archive strategies.

Yahoo Finance 11/02/2023

PathAI Announces New NASH/MASH Advisory Network to Guide Evidence Generation and Regulatory Strategy for AI-Powered Digital Pathology Product Development

PathAI, a precision pathology solutions provider, has announced the creation of a NASH/MASH advisory network. The network, comprising international experts, will guide the development of AI-powered digital pathology products to improve outcomes for those with non-alcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis (NASH/MASH). The advisory network's first meeting took place in September and will meet quarterly.

Other companies like PathAI in the Digital Health sector

Sector: Healthcare

Subsector: Digital Health

					Last Funding Round
Company		Forge Price	Forge Price Change ⁵	Last Closed Trade	Share Class	Post-Money Valuation	Price per Share	Amount Raised
	Alma	--	--	$xx.xx	Series D	$788.56MM	$xx.xx	$130MM
	BetterUp	--	--	$xx.xx	Series E	$4.75B	$xx.xx	$340MM
	Brightline	--	--	$xx.xx	Series C	$705.25MM	$xx.xx	$115.2MM
	Calm	--	--	$xx.xx	Series 1	$404.67MM	$xx.xx	$25.07MM
	Headspace	--	--	$xx.xx	Series B	$298.33MM	$xx.xx	$38.65MM
	Hinge Health	$31.00	-22.11%	$xx.xx	Series E	$6.2B	$xx.xx	$400MM
	OURA	--	--	$xx.xx	--	--	--	--
	Omada Health	--	--	$xx.xx	Series E	$1.02B	$xx.xx	$192MM
	Soufflé Therapeutics	--	--	$xx.xx	Series A	$296.51MM	$xx.xx	$113.53MM
	ZocDoc	$6.33	-8.53%	$xx.xx	Series D-2	$2.62B	$xx.xx	$100MM

See All Companies

Forge is your trusted partner to buy and sell PathAI stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Feb 13, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

PathAI stock